Clinicopathological characteristics of 19 patients whose hormonal concentrations were measured by LC-MS/MS (2012-2013). Parameter n (%). Median (range).
Supplemental Table 1. Clinicopathological characteristics of 19 patients whose hormonal concentrations were measured by LC-MS/MS (2012-2013). Parameter
n (%)
Median (range)
Age
63.2 (51-76)
BMI
24.0 (17.1-31.0)
Grade 1 (G1)
7 (36.8)
2 (G2)
6 (31.6)
3 (G3)
6 (31.6)
Stage Ⅰ
13 (68.5)
Ⅱ
2 (10.5)
Ⅲ
2 (10.5)
Ⅳ
2 (10.5)
MI No or less than half
10 (52.6)
More than half
9 (47.4)
LVI No
7 (36.8)
Yes
12 (63.2)
LN metastasis No
12 (63.2)
Yes
0 (0)
Not resected
7 (36.8)
Adjuvant therapy No
9 (47.4)
Yes
10 (52.6)
BMI, body mass index; MI, myometrial invasion; LVI, lymphovascular invasion; LN, lymph node. We performed lymphadenectomy for 12 cases, and did not resect any lymph node in 7 cases (not resected).
1
Supplemental Table 2. Clinicopathological characteristics of 53 patients with EEA (19932001). Parameter
n (%)
Median (range)
Age
61 (51-85)
Follow-up period (months)
85 (8-123)
Relapse or progression
7 (13.2)
Death Total
6 (11.3)
Death with EEA
5 (9.4)
Death of the other cause
1 (1.9)
Stage (FIGO 2009) I
45 (84.9)
II
0 (0.0)
III
6 (11.3)
IV
2 (3.8)
Grade G1
22 (41.5)
G2
20 (37.7)
G3
11 (20.8)
MI None or less than half
31 (58.5)
More than half
22 (41.5)
LVI No
37 (69.8)
Yes
16 (30.2)
LN metastases Negative
39 (73.6)
Positive
3 (5.7)
Not resected
11 (20.7)
Adjuvant therapy No
22 (41.5)
Yes
31 (58.5)
MI, myometrial invasion; LVI, lymphovascular invasion; LN, lymph node. We performed lymphadenectomy for 42 cases, and did not resect any lymph node in 11 cases (not resected).
